Testing violations of the exponential assumption in cancer clinical trials with survival endpoints

DOI10.1111/BIOM.12590zbMath1372.62068OpenAlexW2524127088WikidataQ39350574 ScholiaQ39350574MaRDI QIDQ5283334

Christos Hatzis, Gang Han, Lajos Pusztai, Kerin Adelson, Michael J. Schell, Daniel Zelterman, Heping Zhang

Publication date: 21 July 2017

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc6093291

zbMATH Keywords

failure ratesurvival analysiscensoringuniformly most powerful unbiased testchange-point modeling

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Testing in survival analysis and censored data (62N03)

Cites Work

• Unnamed Item
• Generalized Pearson-Fisher chi-square goodness-of-fit tests, with applications to models with life history data
• Chi-square goodness-of-fit test for randomly censored data
• Recent and classical tests for exponentiality: a partial review with comparisons
• Small-Sample Properties of Censored-Data Rank Tests
• What Price Kaplan-Meier?
• Pearson-Type Goodness-of-Fit Tests: The Univariate Case
• Testing to Determine the Underlying Distribution Using Randomly Censored Data
• Goodness-of-fit tests for randomly censored data
• The Reduced Monotonic Regression Method
• The Price of Kaplan–Meier

This page was built for publication: Testing violations of the exponential assumption in cancer clinical trials with survival endpoints